Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients with Stage III Soft Tissue Sarcomas of the Extremity By Ogkologos - December 2, 2024 205 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SU2C-SARC032 study Source RELATED ARTICLESMORE FROM AUTHOR Adding Retifanlimab To First-Line Chemotherapy for Patients with Advanced Squamous Cell Anal Cancer Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab Alone in Patients with ES-SCLC FDA Grants Accelerated Approval to Datopotamab Deruxtecan-dlnk for EGFR-mutated Non-Small Cell Lung Cancer MOST POPULAR Teacher’s Mental Health Check-In Board Goes Viral For The ‘Beautiful’ Standard... April 11, 2019 FDA Approves Encorafenib with Binimetinib for Metastatic Non-Small Cell Lung Cancer... October 16, 2023 First-Line Treatment with Encorafenib Plus Cetuximab Plus mFOLFOX6 Significantly Improves ORR... February 17, 2025 Distinct Patient, Tumour, Treatment Characteristics and a Different Pattern and Risk... March 10, 2025 Load more HOT NEWS Women in science: Cancer research pioneers – part 1 Largest Study on Frequent Aspirin Use Supports Reduction in Ovarian Cancer... A Diagnosis of Advanced Lung Cancer Is Not a Death Sentence Cancer in My Community: Overcoming Inequities in Care in Argentina
